Company Filing History:
Years Active: 2021
Title: Martin Will - Innovator in Insulin Conjugates
Introduction
Martin Will is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin conjugates. His innovative work has led to the filing of a patent that addresses important advancements in insulin analogs.
Latest Patents
Martin Will holds a patent for "Insulin conjugates." This invention relates to a conjugate comprising a sulfonamide of a specific formula and an active pharmaceutical ingredient, such as an insulin analog. The insulin analog includes at least one mutation relative to the parent insulin, specifically mutations at positions B16 and B25, which are substituted with hydrophobic amino acids. This innovative approach aims to enhance the efficacy of insulin treatments.
Career Highlights
Martin Will is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical science.
Collaborations
Throughout his career, Martin has collaborated with talented professionals, including Maria Mendez Perez and Nils Rackelmann. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Martin Will is a distinguished inventor whose work in insulin conjugates represents a significant advancement in pharmaceutical science. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.